Crest Ventures Q2 FY26: Sharp Profit Decline Raises Serious Concerns

Nov 17 2025 09:35 PM IST
share
Share Via
Crest Ventures Ltd., a Mumbai-based non-banking financial company, reported deeply concerning second-quarter results for FY2026, with consolidated net profit plunging 78.28% year-on-year to ₹3.72 crores from ₹17.13 crores in Q2 FY25. The sequential decline was even more dramatic, with profits collapsing 85.23% from ₹25.19 crores in Q1 FY26. The stock, trading at ₹367.75 with a market capitalisation of ₹1,036 crores, fell 3.21% following the results announcement, reflecting investor alarm over the sharp deterioration in financial performance.



The micro-cap NBFC's revenue fell 16.51% year-on-year to ₹29.54 crores in Q2 FY26, whilst also contracting 53.19% sequentially from ₹63.11 crores in Q1 FY26. Operating margins collapsed to 40.15% from 72.16% a year ago, marking the lowest quarterly margin in recent history. The results underscore mounting operational challenges and raise questions about the sustainability of the company's business model in the current environment.





Consolidated Net Profit

₹3.72 Cr

▼ 78.28% YoY



Net Sales

₹29.54 Cr

▼ 16.51% YoY



Operating Margin

40.15%

▼ 3,201 bps YoY



PAT Margin

12.63%

▼ 3,794 bps YoY




The magnitude of the profit decline has sent shockwaves through the investment community. What makes this quarter particularly alarming is not just the year-on-year comparison, but the sequential deterioration. After posting a relatively strong Q1 FY26 with ₹25.19 crores in consolidated profit, the company experienced an 85.23% collapse in just three months. This pattern suggests operational disruptions rather than seasonal variations, pointing to deeper structural issues within the business.









































































Quarter Net Sales (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change Operating Margin
Sep'25 29.54 -53.19% 3.72 -85.23% 40.15%
Jun'25 63.11 +32.70% 25.19 +225.87% 67.23%
Mar'25 47.56 +8.14% 7.73 -46.80% 42.54%
Dec'24 43.98 +24.31% 14.53 -15.18% 54.66%
Sep'24 35.38 -54.27% 17.13 -65.23% 72.16%
Jun'24 77.36 +94.42% 49.26 +318.88% 87.14%
Mar'24 39.79 11.76 55.59%



Financial Performance: A Quarter of Deterioration



The financial metrics for Q2 FY26 paint a troubling picture across virtually every parameter. Net sales of ₹29.54 crores represent the lowest quarterly revenue in the recent tracking period, falling well below the company's recent run rate. The 53.19% quarter-on-quarter contraction is particularly concerning, suggesting significant business disruption rather than normal cyclical patterns.



Operating profit before depreciation, interest, and tax (PBDIT) excluding other income collapsed to ₹11.86 crores from ₹42.43 crores in Q1 FY26, marking a 72.05% sequential decline. The operating margin of 40.15% represents a dramatic compression from 67.23% in the previous quarter and 72.16% a year ago. This 3,201 basis point year-on-year margin erosion signals severe pressure on the company's core business operations.



The profit cascade reveals multiple pressure points. Interest costs remained elevated at ₹4.98 crores, whilst operating profit fell sharply. Profit before tax stood at just ₹5.59 crores, the lowest quarterly figure recorded. After accounting for taxes of ₹1.85 crores at an effective rate of 33.09%, consolidated net profit settled at a mere ₹3.72 crores. The PAT margin of 12.63% compares unfavourably to 50.57% in Q2 FY25 and 40.79% in Q1 FY26.





Revenue (Q2 FY26)

₹29.54 Cr

▼ 53.19% QoQ



Net Profit (Q2 FY26)

₹3.72 Cr

▼ 85.23% QoQ



Operating Margin

40.15%

Lowest on record



PAT Margin

12.63%

▼ from 50.57% YoY




Employee costs increased to ₹8.28 crores from ₹6.16 crores a year ago, representing a 34.42% rise even as revenues contracted. This divergence between cost growth and revenue decline suggests operational inefficiencies and raises questions about the company's cost management capabilities. The operating profit to interest coverage ratio fell to just 2.38 times, the lowest level recorded, indicating deteriorating debt servicing capacity.



Operational Challenges: Profitability Under Severe Pressure



The company's return ratios tell a story of deteriorating operational efficiency. The return on capital employed (ROCE) for the half-year period stood at just 5.61%, marking the lowest level on record. This compares to a historical average ROCE of 14.08%, indicating a substantial erosion in capital productivity. The latest annual ROCE of 7.38% already signalled weakness, but the half-yearly figure suggests accelerating deterioration.



Return on equity (ROE) has similarly weakened, with the latest annual figure at 4.28% compared to the five-year average of 11.23%. Whilst the average ROE of 11.23% demonstrates that Crest Ventures historically generated reasonable returns on shareholder capital, the recent collapse to 4.28% represents a significant concern. This level of return barely exceeds risk-free rates, questioning whether the company is adequately compensating shareholders for the risks inherent in NBFC operations.



The balance sheet presents a mixed picture. Shareholder funds stood at ₹1,194.81 crores as of March 2025, up from ₹1,104.62 crores a year earlier, reflecting retained earnings accumulation. The company maintains a debt-free status on long-term borrowings, with current liabilities of ₹240.51 crores. Investments totalled ₹341.41 crores, whilst current assets stood at ₹525.53 crores. The book value per share of ₹380.03 provides some valuation support, though operational concerns overshadow this metric.




Critical Alert: Profitability Collapse


Immediate Concerns:



  • Quarterly profit down 78.28% YoY and 85.23% QoQ

  • Operating margins at multi-quarter lows of 40.15%

  • ROCE at lowest recorded level of 5.61%

  • Operating profit to interest coverage at concerning 2.38x

  • Revenue contraction of 53.19% quarter-on-quarter


The magnitude and persistence of these declines suggest structural rather than cyclical challenges.




Industry Context: Underperformance Across Metrics



Crest Ventures' struggles stand in stark contrast to the broader NBFC sector performance. The company's stock has declined 18.28% over the past year, significantly underperforming the NBFC sector return of 2.93% by 21.21 percentage points. This substantial underperformance reflects investor concerns about company-specific challenges rather than sector-wide headwinds.



The company's five-year sales growth of 23.51% and EBIT growth of 34.54% demonstrate historical expansion capability. However, recent quarterly trends suggest this growth trajectory has reversed sharply. The disconnect between long-term growth metrics and recent quarterly performance raises questions about sustainability and the factors driving current weakness.



From a risk-return perspective, Crest Ventures presents an unfavourable profile. The stock exhibits high volatility of 48.56% with negative risk-adjusted returns of -0.38 over the past year. This places it firmly in the "high risk, low return" category. The beta of 1.50 indicates the stock is 50% more volatile than the broader market, amplifying downside risks during market corrections.

































































Company P/E (TTM) P/BV ROE % Debt/Equity Div Yield
Crest Ventures 20.45 0.88 11.23% 0.07 0.25%
Saraswati Commercial 67.19 1.35 12.84% 0.05
Ashika Credit NA (Loss Making) 2.16 9.08% 0.00
LKP Finance NA (Loss Making) 4.16 13.44% 0.10
Capital India NA (Loss Making) 1.99 0.54% 1.59 0.06%
Vardhman Holdings 4.97 0.32 8.51% 0.00 0.13%



Relative to NBFC peers, Crest Ventures trades at a P/E of 20.45x, which appears reasonable compared to Saraswati Commercial's 67.19x. However, the company's 0.88x price-to-book ratio, whilst below several peers, fails to account for the sharp deterioration in profitability. The average ROE of 11.23% positions Crest Ventures in the middle of the peer group, but the latest annual ROE of 4.28% suggests this comparative advantage is eroding rapidly.



Valuation Analysis: Premium Unjustified by Fundamentals



Despite the operational challenges, Crest Ventures trades at what the proprietary assessment classifies as "Very Expensive" valuation levels. The P/E ratio of 20.45x appears elevated given the sharp profit decline and uncertain earnings trajectory. With quarterly profits collapsing 78.28% year-on-year, the trailing twelve-month earnings base supporting this multiple is rapidly deteriorating.



The price-to-book ratio of 0.88x provides some downside protection, trading below the net asset value of ₹380.03 per share versus the current price of ₹367.75. However, this discount may simply reflect market concerns about asset quality and future profitability rather than presenting a value opportunity. The EV/EBITDA multiple of 11.46x and EV/Sales of 6.13x appear stretched given the margin compression and revenue challenges.



The stock has declined 27.74% from its 52-week high of ₹508.95, reflecting the market's reassessment of the company's prospects. Trading 20.75% above the 52-week low of ₹304.55, the current price level offers limited margin of safety given the deteriorating fundamentals. The dividend yield of 0.25% provides negligible income support, with the latest dividend of ₹1 per share representing a meagre 4.69% payout ratio.





P/E Ratio (TTM)

20.45x

vs Industry 42x



Price to Book

0.88x

12% discount to NAV



EV/EBITDA

11.46x

Elevated multiple



Dividend Yield

0.25%

Minimal income




The valuation grade history reveals a dramatic shift in market perception. The stock moved from "Very Attractive" in November 2022 to "Very Expensive" by August 2023, and has remained at elevated valuation levels despite the recent profit collapse. This suggests the market has yet to fully price in the deteriorating fundamentals, potentially leaving room for further downside.



Shareholding: Stable Promoter Base Amid Institutional Absence



The shareholding pattern reveals a promoter-dominated structure with limited institutional participation. Promoter holding stood at 69.75% as of September 2025, unchanged from June 2025 but up from 69.11% in December 2024. The gradual increase in promoter stake over recent quarters demonstrates continued commitment, though this has not translated into improved operational performance.

























































Quarter Promoter % QoQ Change FII % MF % Non-Inst %
Sep'25 69.75% 0.00% 1.63% 0.00% 28.62%
Jun'25 69.75% +0.29% 1.63% 0.00% 28.62%
Mar'25 69.46% +0.35% 1.50% 0.00% 29.04%
Dec'24 69.11% 0.00% 1.43% 0.00% 29.46%
Sep'24 69.11% 1.42% 0.00% 29.47%



Foreign institutional investor (FII) holding remains minimal at 1.63%, with just six FII holders. The absence of mutual fund holdings is particularly noteworthy, suggesting professional fund managers see limited value or excessive risk in the stock. Insurance companies similarly maintain zero exposure. The 28.62% non-institutional holding represents largely retail investors, who may lack the resources to conduct deep fundamental analysis.



The absence of institutional investors serves as a red flag. Mutual funds and insurance companies typically conduct rigorous due diligence before investing, and their complete absence from the shareholder register suggests concerns about the company's business model, governance, or growth prospects. The minimal FII presence of 1.63% reinforces this cautious stance from sophisticated investors.



Stock Performance: Significant Underperformance Across Timeframes



The stock's price performance reflects growing investor concerns about the company's prospects. Over the past year, Crest Ventures has declined 18.28% whilst the Sensex gained 9.50%, resulting in negative alpha of 27.78 percentage points. This substantial underperformance has persisted across multiple timeframes, with the stock declining 13.57% year-to-date against an 8.72% Sensex gain.































































Period Stock Return Sensex Return Alpha
1 Week -0.77% +1.69% -2.46%
1 Month +4.24% +1.19% +3.05%
3 Months -1.13% +5.40% -6.53%
6 Months -6.88% +3.18% -10.06%
YTD -13.57% +8.72% -22.29%
1 Year -18.28% +9.50% -27.78%
2 Years +17.93% +29.12% -11.19%
3 Years +111.29% +37.57% +73.72%



The longer-term performance presents a contrasting picture. Over three years, the stock has gained 111.29%, substantially outperforming the Sensex's 37.57% return with positive alpha of 73.72 percentage points. The five-year return of 323.43% versus the Sensex's 93.28% demonstrates the stock's historical wealth creation capability. However, this strong long-term track record has reversed sharply in recent periods, with all short to medium-term timeframes showing negative alpha.



From a technical perspective, the stock trades in a "Mildly Bearish" trend, having changed from "Bearish" on November 13, 2025. The stock trades below all key moving averages, with the 5-day MA at ₹372.02, 20-day MA at ₹374.19, 100-day MA at ₹376.34, and 200-day MA at ₹386.11. This alignment of moving averages in descending order confirms the negative technical momentum.




"The combination of collapsing profitability, elevated valuations, absent institutional support, and negative technical trends creates a particularly unfavourable risk-reward profile for investors."


Investment Thesis: Multiple Red Flags Outweigh Limited Positives



The investment case for Crest Ventures has deteriorated significantly following the Q2 FY26 results. The company's proprietary Mojo Score stands at just 24 out of 100, firmly in "Strong Sell" territory. This assessment reflects the confluence of negative factors across valuation, quality, financial trends, and technical indicators.



The financial trend is classified as "Negative," driven by the lowest quarterly net sales, PBDIT, profit before tax, and operating margins on record. The ROCE for the half-year period of 5.61% marks a multi-year low, whilst the operating profit to interest coverage ratio of 2.38 times raises concerns about debt servicing capacity. These metrics suggest structural challenges rather than temporary headwinds.



The quality assessment of "Average" reflects mixed signals. Whilst the company maintains healthy long-term growth metrics with 23.51% sales CAGR and 34.54% EBIT CAGR over five years, recent performance contradicts this historical strength. The absence of promoter pledging provides some comfort, but the minimal 1.63% institutional holding suggests sophisticated investors remain unconvinced about the company's prospects.



The valuation grade of "Very Expensive" appears particularly concerning given the deteriorating fundamentals. Trading at a P/E of 20.45x with profits collapsing 78.28% year-on-year creates significant downside risk if earnings continue to disappoint. The technical trend of "Mildly Bearish" with the stock below all moving averages reinforces the negative momentum.





Key Strengths



  • Strong Long-Term Track Record: Five-year returns of 323.43% demonstrate historical wealth creation capability

  • Debt-Free Balance Sheet: Zero long-term debt provides financial flexibility

  • No Promoter Pledging: Zero pledged shares indicate promoter confidence

  • Solid Shareholder Funds: ₹1,194.81 crores in equity capital provides cushion

  • Historical Growth: 23.51% sales CAGR and 34.54% EBIT CAGR over five years

  • Valuation Discount to Book: P/BV of 0.88x trades below net asset value




Key Concerns



  • Profit Collapse: Net profit down 78.28% YoY and 85.23% QoQ in Q2 FY26

  • Margin Compression: Operating margin at 40.15%, down from 72.16% a year ago

  • Revenue Decline: Sales down 16.51% YoY and 53.19% QoQ

  • Deteriorating Returns: ROCE at 5.61%, lowest on record; ROE at 4.28%

  • Weak Coverage: Operating profit to interest at concerning 2.38x

  • Institutional Absence: Zero mutual fund and minimal FII holdings

  • Negative Momentum: Stock down 18.28% over one year with negative alpha

  • Elevated Valuation: "Very Expensive" grade despite deteriorating fundamentals





Outlook: Critical Monitoring Points Ahead



The path forward for Crest Ventures depends critically on management's ability to arrest the profit decline and restore operational momentum. Investors should closely monitor the Q3 FY26 results for signs of stabilisation or further deterioration. Key metrics to watch include revenue trends, margin recovery, and return ratio improvements.





Positive Catalysts



  • Revenue stabilisation in Q3 FY26

  • Margin recovery towards historical 55-60% levels

  • ROCE improvement above 10%

  • Institutional investor entry

  • Management commentary on turnaround strategy




Red Flags



  • Further sequential profit decline in Q3 FY26

  • Continued margin compression below 40%

  • ROCE remaining below 6%

  • Additional institutional exit or absence

  • Break below ₹304.55 support level





The technical setup suggests limited near-term upside, with resistance at ₹374.19 (20-day MA), ₹376.34 (100-day MA), and ₹386.11 (200-day MA). A sustained break above these levels would be required to signal a trend reversal. Conversely, a break below the 52-week low of ₹304.55 could trigger further selling pressure.



From a fundamental perspective, the company needs to demonstrate that Q2 FY26 represents a temporary aberration rather than the beginning of a sustained downturn. Management commentary on the factors driving the profit collapse and concrete steps to address them will be critical. Without clear evidence of operational improvement, the stock faces continued pressure from both fundamental and technical perspectives.




The Verdict: Avoid Until Turnaround Evidence Emerges


STRONG SELL

Score: 24/100


For Fresh Investors: Avoid initiating positions. The 78.28% year-on-year profit decline, collapsing margins, deteriorating return ratios, and elevated valuation create an unfavourable risk-reward profile. Wait for concrete evidence of operational stabilisation and margin recovery before considering entry.


For Existing Holders: Consider reducing exposure or exiting positions. The magnitude of the profit decline and sequential deterioration suggest structural challenges requiring time to resolve. The absence of institutional support and negative technical momentum reinforce the case for caution. Protect capital and reassess after Q3 FY26 results demonstrate stabilisation.


Fair Value Estimate: ₹280-₹300 (24-18% downside risk from current levels)





Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Crest Ventures falling/rising?
Nov 28 2025 12:14 AM IST
share
Share Via
Why is Crest Ventures falling/rising?
Nov 19 2025 09:48 PM IST
share
Share Via
How has been the historical performance of Crest Ventures?
Nov 14 2025 11:36 PM IST
share
Share Via
Is Crest Ventures technically bullish or bearish?
Nov 14 2025 08:11 AM IST
share
Share Via